» Articles » PMID: 22777359

Cancer-associated Lysosomal Changes: Friends or Foes?

Overview
Journal Oncogene
Date 2012 Jul 11
PMID 22777359
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

Rapidly dividing and invasive cancer cells are strongly dependent on effective lysosomal function. Accordingly, transformation and cancer progression are characterized by dramatic changes in lysosomal volume, composition and cellular distribution. Depending on one's point of view, the cancer-associated changes in the lysosomal compartment can be regarded as friends or foes. Most of them are clearly transforming as they promote invasive growth, angiogenesis and drug resistance. The same changes can, however, strongly sensitize cells to lysosomal membrane permeabilization and thereby to lysosome-targeting anti-cancer drugs. In this review we compile our current knowledge on cancer-associated changes in lysosomal composition and discuss the consequences of these alterations to cancer progression and the possibilities they can bring to cancer therapy.

Citing Articles

Bafilomycin A1 induces colon cancer cell death through impairment of the endolysosome system dependent on iron.

Min D, Kim D, Hong S, Kim J, Kim M, Kwon S Sci Rep. 2025; 15(1):5148.

PMID: 39934167 PMC: 11814099. DOI: 10.1038/s41598-025-89127-5.


Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer.

Nehme J, Maassen S, Bravaccini S, Zanoni M, Gianni C, De Giorgi U EMBO J. 2025; .

PMID: 39930269 DOI: 10.1038/s44318-025-00371-x.


GANT61 surmounts drug resistance of ADR by upregulating lysosome activities and reducing BCL2 expression in HL-60/ADR cells.

Zhou C, Zhao L, Zhou M, Wu C, Liu G, Long J Cancer Cell Int. 2024; 24(1):430.

PMID: 39726048 PMC: 11674180. DOI: 10.1186/s12935-024-03626-5.


Development of a prognostic model based on lysosome-related genes for ovarian cancer: insights into tumor microenvironment, mutation patterns, and personalized treatment strategies.

Sun R, Li S, Ye W, Lu Y Cancer Cell Int. 2024; 24(1):419.

PMID: 39702158 PMC: 11661007. DOI: 10.1186/s12935-024-03586-w.


Lysosome-Associated Membrane Protein-3 (LAMP3) Expression in Oral Squamous Cell Carcinoma and Its Relationship With Clinicopathological Parameters: A Cross-Sectional Study.

Jeyapriya M, Kumar S, Nirmal M Cureus. 2024; 16(9):e69790.

PMID: 39429383 PMC: 11491047. DOI: 10.7759/cureus.69790.